Clinical Trial

Omics Profiling of Weight Loss with Bariatric Surgery

Study Description

Omics Profiling of Weight Loss With Bariatric Surgery

Understanding how foods and nutrients are digested, absorbed and metabolized when weight is stable and during weight loss induced by bariatric surgery procedure using the technologies of genomics, transcriptomics, proteomics, metabolomics and fluxomics ("omics") will enable generation of new hypotheses that could explain the inter-individual differences in weight loss and could lead to optimization and individualization of therapies designed to lose weight.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Stable isotope infusion

such as glycerol, D2O, tyrosine, phenylalanine, glucose, arginine, and citrulline

Additional Information

Official Study Title

Omics Profiling of the Response to Food and Variability of Weight Loss With Bariatric Surgery

Clinical Trial ID

NCT02757638

ParticipAid ID

PdyA6d